Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab

We report a patient with idiopathic hypereosinophilic syndrome (I‐HES) who achieved remission with benralizumab after relapsing on mepolizumab. An 83‐year‐old man was admitted to Showa General Hospital after presenting with hypoxaemia and multiple erythematous lesions. He showed a marked increase in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Koki, Takahashi, Hidenori, Hayakawa, Nami, Iwasaki, Yoshinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511777/
https://www.ncbi.nlm.nih.gov/pubmed/33005423
http://dx.doi.org/10.1002/rcr2.665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511777/
https://www.ncbi.nlm.nih.gov/pubmed/33005423
http://dx.doi.org/10.1002/rcr2.665

Ejemplares similares